日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting : R-EFECT study

奥地利一项多中心回顾性研究评估了慢性粒细胞白血病 (CML) 的治疗情况,旨在评估早期治疗反应对真实世界患者预后的影响:R-EFECT 研究

Petzer, Andreas L; Sperr, Wolfgang R; Buxhofer-Ausch, Veronika; Sliwa, Thamer; Schmidt, Stefan; Greil, Richard; Wölfler, Albert; Pichler, Petra; Dormann, Clemens; Burgstaller, Sonja; Tinchon, Christoph; Lang, Alois; Goebel, Florian; Uthman, Shanow; Muenchmeier, Niklas; Valent, Peter

Membrane-anchored chemokine fusion proteins: A novel class of adjuvants for immunotherapy

膜锚定趋化因子融合蛋白:一类新型免疫治疗佐剂

Nelson, Peter J; Muenchmeier, Niklas

A novel CXCL10-based GPI-anchored fusion protein as adjuvant in NK-based tumor therapy.

一种新型的基于 CXCL10 的 GPI 锚定融合蛋白作为 NK 细胞肿瘤治疗的佐剂

Muenchmeier Niklas, Boecker Sophia, Bankel Lorenz, Hinz Laura, Rieth Nicole, Lapa Constantin, Mendler Anna N, Noessner Elfriede, Mocikat Ralph, Nelson Peter J